These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36373411)

  • 1. Humoral and cellular immunogenicity and efficacy of a coxsackievirus A10 vaccine in mice.
    An HH; Li M; Liu RL; Wu J; Meng SL; Guo J; Wang ZJ; Qian SS; Shen S
    Emerg Microbes Infect; 2023 Dec; 12(1):e2147022. PubMed ID: 36373411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Coxsackievirus A5 Vaccine Candidates in an Actively Immunized Mouse Model.
    Jin WP; Lu J; Zhang XY; Wu J; Wei ZN; Mai JY; Qian SS; Yu YT; Meng SL; Wang ZJ; Shen S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a coxsackievirus A6 vaccine candidate in an actively immunized mouse model.
    Qian SS; Wei ZN; Jin WP; Wu J; Zhou YP; Meng SL; Guo J; Wang ZJ; Shen S
    Emerg Microbes Infect; 2021 Dec; 10(1):763-773. PubMed ID: 33739899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Coxsackievirus A2 vaccine candidates correlating to humoral immunity in mice challenged with a mouse-adapted strain.
    Hu G; Jin WP; Yang ZH; Lv SY; Wu J; Yu YT; Meng SL; Guo J; Wang ZJ; Shen S
    Vaccine; 2022 Aug; 40(33):4716-4725. PubMed ID: 35760737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.
    Liu CC; Guo MS; Wu SR; Lin HY; Yang YT; Liu WC; Chow YH; Shieh DB; Wang JR; Chong P
    Antiviral Res; 2016 May; 129():58-66. PubMed ID: 26899790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease.
    Lim H; In HJ; Lee JA; Sik Yoo J; Lee SW; Chung GT; Choi YK; Chung JK; Cho SJ; Lee JW
    Vaccine; 2018 Jun; 36(24):3445-3452. PubMed ID: 29739716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection.
    Zhang Z; Dong Z; Li J; Carr MJ; Zhuang D; Wang J; Zhang Y; Ding S; Tong Y; Li D; Shi W
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28424287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a neutralizing linear epitope within the VP1 protein of coxsackievirus A10.
    Zhu H; Liu X; Wu Y; He Y; Zheng H; Liu H; Liu Q
    Virol J; 2022 Dec; 19(1):203. PubMed ID: 36457099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy.
    Zhang Z; Dong Z; Wei Q; Carr MJ; Li J; Ding S; Tong Y; Li D; Shi W
    J Virol; 2017 May; 91(9):. PubMed ID: 28250116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice.
    Zhang Z; Dong Z; Wang Q; Carr MJ; Li J; Liu T; Li D; Shi W
    Vaccine; 2018 Nov; 36(46):7095-7104. PubMed ID: 30316529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge.
    Shen C; Liu Q; Zhou Y; Ku Z; Wang L; Lan K; Ye X; Huang Z
    Vaccine; 2016 Sep; 34(41):5005-5012. PubMed ID: 27562093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of EV71 vaccine candidates.
    Chong P; Hsieh SY; Liu CC; Chou AH; Chang JY; Wu SC; Liu SJ; Chow YH; Su IJ; Klein M
    Hum Vaccin Immunother; 2012 Dec; 8(12):1775-83. PubMed ID: 22992566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and immunodominant linear B-cell epitopes of a new DNA-based tetravalent vaccine against four major enteroviruses causing hand, foot, and mouth disease.
    Maje Bello A; Chaimongkolnukul K; Poomputsa K; Mekvichitsaeng P; Maprang Roshorm Y
    Vaccine; 2024 Jun; 42(17):3733-3743. PubMed ID: 38705805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation characteristics of coxsackievirus A10 in mice and immune protection ability of experimental inactivated vaccine.
    Gao W; Yue L; Yang T; Shen D; Li H; Song X; Xie T; He X; Xie Z
    Biomed Pharmacother; 2021 Nov; 143():112212. PubMed ID: 34649345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease.
    Fang CY; Liu CC
    Expert Rev Vaccines; 2018 Sep; 17(9):819-831. PubMed ID: 30095317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection from lethal challenge in a neonatal mouse model by circulating recombinant form coxsackievirus A16 vaccine candidates.
    Li J; Chang J; Liu X; Yang J; Guo H; Wei W; Zhang W; Yu XF
    J Gen Virol; 2014 May; 95(Pt 5):1083-1093. PubMed ID: 24496826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant virus-like particle presenting a newly identified coxsackievirus A10 neutralization epitope induces protective immunity in mice.
    Dai W; Xiong P; Zhang X; Liu Z; Chen J; Zhou Y; Ye X; Zhang C
    Antiviral Res; 2019 Apr; 164():139-146. PubMed ID: 30817941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of an inactivated bivalent vaccine for enterovirus 71 and coxsackievirus A16 in mice immunized intradermally.
    Fan S; Liao Y; Jiang G; Wang L; Zhao H; Yu L; Xu X; Li D; Zhang Y; Li Q
    Vaccine; 2021 Jan; 39(3):596-604. PubMed ID: 33342637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propagation and immunological characterization of coxsackievirus A10 in a serum-free HEK293A cell culture system.
    Lien SC; Shen YS; Lin HY; Wu SR; Fang CY; Chen CH; Chen YA; Chong PC; Huang MH; Chow YH; Wang JR; Wu SC; Liu CC
    Virus Res; 2023 May; 329():199101. PubMed ID: 36958398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hand, foot, and mouth disease associated with coxsackievirus A10: more serious than it seems.
    Bian L; Gao F; Mao Q; Sun S; Wu X; Liu S; Yang X; Liang Z
    Expert Rev Anti Infect Ther; 2019 Apr; 17(4):233-242. PubMed ID: 30793637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.